beryllium nitrate has been researched along with Hepatorenal Syndrome in 1 studies
*Hepatorenal Syndrome: Functional KIDNEY FAILURE in patients with liver disease, usually LIVER CIRRHOSIS or portal hypertension (HYPERTENSION, PORTAL), and in the absence of intrinsic renal disease or kidney abnormality. It is characterized by intense renal vasculature constriction, reduced renal blood flow, OLIGURIA, and sodium retention. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Agrawal, OP; Bhadauria, M; Li, PQ; Mathur, A; Mathur, R; Nirala, SK; Shukla, S | 1 |
1 other study(ies) available for beryllium nitrate and Hepatorenal Syndrome
| Article | Year |
|---|---|
Pharmacological intervention of tiferron and propolis to alleviate beryllium-induced hepatorenal toxicity.
Topics: Animals; Antioxidants; Benzenesulfonates; Beryllium; Chelating Agents; Cytochrome P-450 Enzyme System; Drug Synergism; Drug Therapy, Combination; Female; Hepatorenal Syndrome; Kidney; Kidney Function Tests; Lipid Peroxidation; Liver; Liver Function Tests; Nitrates; Propolis; Rats; Rats, Sprague-Dawley | 2008 |